RxDoctor Payments Data

Kevin Temple, NP

Family · Victoria, TXNPI 1790152346

Payments from drug & device makers

$1,990in general payments, 2019–2025

Across 125 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$515
  • AstraZeneca$501
  • Novartis$298
  • Abbott$238
  • Merck$140
  • Johnson & Johnson$121
  • plus $177 from 6 others

What the payments were for

  • Food & beverage$1,990100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,990 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$55,671
Medicare patients
547
Services billed
729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban147$144,718
XareltoRivaroxaban54$53,452
BrilintaTicagrelor21$17,113
Repatha SureclickEvolocumab21$13,586
Metoprolol Succinate240$2,834
Amiodarone Hcl48$2,634
Flecainide Acetate30$1,871
Atorvastatin Calcium185$1,374
Valsartan55$1,351
Losartan Potassium150$1,134
ClopidogrelClopidogrel Bisulfate135$1,101
Diltiazem 24hr Er (Cd)Diltiazem Hcl43$1,025
Ezetimibe28$950
Amlodipine Besylate171$949
SotalolSotalol Hcl48$865

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$121$53,45254 claims
AstraZenecaBrilinta$501$17,11321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 15,456 family providers in Texas.

Other family in Victoria

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →